Association of tamoxifen use and reduced risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers

Ítems similars

• Tamoxifen and Risk of Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
  per: Phillips, Kelly-Anne, et al.
  Publicat: (2013)
• Oral contraceptives and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS)
  per: Rookus, MA, et al.
  Publicat: (2005)
• Low-dose ionizing radiation significantly increases the risk of breast cancer among BRCA1/2 mutation carriers in the International BRCA1/2 Carrier Cohort Study (IBCCS)
  per: Van Leeuwen, FE, et al.
  Publicat: (2005)
• Adequacy of risk-reducing gynaecologic surgery in BRCA1 or BRCA2 mutation carriers and other women at high risk of pelvic serous cancer
  per: Kiely, B. E., et al.
  Publicat: (2011)
• An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA)
  per: Chenevix-Trench, Georgia, et al.
  Publicat: (2007)